The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Follow-up on phase 1 study of AT101, a novel anti-CD19 chimeric antigen receptor cell therapy (CAR-T) in patients with relapsed or refractory (r/r) b-cell non-Hodgkin lymphoma.
 
Ki Hyun Kim
Employment - AbClon
 
Dok Hyun Yoon
Honoraria - Celgene; Janssen; Kirin Pharmaceuticals; Roche; Takeda
Consulting or Advisory Role - ABclonal; Amgen; Celgene; GI cell; Janssen; Novartis; Pharos iBio; Roche
Research Funding - Boryung; Celltrion (Inst); Janssen Oncology; Roche/Genentech; Samyang
 
Jae-Cheol Jo
No Relationships to Disclose
 
Seong Hyun Jeong
No Relationships to Disclose
 
Sung Yong Oh
No Relationships to Disclose
 
Hyungwoo Cho
No Relationships to Disclose
 
Yoon Seok Choi
No Relationships to Disclose
 
Sung-Hyun Kim
No Relationships to Disclose
 
Ji Hyun Lee
No Relationships to Disclose
 
LeiGuang Cui
Employment - AbClon
 
Tae-bum Lee
Employment - AbClon
 
In-Sik Hwang
Employment - AbClon
 
Young-Ha Lee
Employment - AbClon
 
Yong-Jun Lee
Employment - AbClon
 
Yoon Lee
Employment - AbClon
 
Jong-Hoon Kim
Employment - AbClon
 
Jong-Seo Lee
Employment - AbClon
 
Junho Chung
No Relationships to Disclose